Novavax stock surges after vaccine maker signs a $1.2 billion licensing deal with France’s Sanofi, guidance from Akamai Technologies misses estimates, and Elon Musk says Tesla to spend more than $500 million to expand its Supercharger network.
The company reporsstrong performances in its security-software and cloud-computing arms, offset by weakness in its legacy content-delivery network segment.
Insightful Analysis of Akamai Technologies Inc's Strengths, Weaknesses, Opportunities, and Threats